Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Bayer AG News Editors

News Widget

Display the Bayer AG news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Bayer AG News

News on Bayer AG (Ticker: BAYRY) continually updated from thousands of sources around the net.

Friday May 25 | Customer Interaction Solutions

Research and Markets: Four-S Fortnightly PharmaHealth Track -...

Research and Markets: Four-S Fortnightly PharmaHealth Track - Newsletter on Indian Healthcare Industry - Issue 5 - Cipla Makes Significant Price Cuts on 3 Cancer Drugs Research and Markets has announced the addition of the "Four-S Fortnightly PharmaHealth Track - Newsletter on Indian Healthcare Industry - Issue 5" report to their offering.

Comment?

Related Topix: Manufacturing, Biotech, Chemicals

Thu May 24, 2012

PR-inside.com

Bayer CropScience's Meredith Lawhon And Bekah Mahan Honored With Triangle Business Journal Awards

RESEARCH TRIANGLE PARK, NC - Planting seeds of beneficial change in the local community and growing a positive company culture are just a few of the specialties of Meredith Lawhon and Bekah Mahan, Bayer CropScience employees who were honored with 2012 "40 Under 40" leadership awards from the Triangle Business Journal recently.

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, Research Triangle Park, NC, Agriculture, Science

Tajikistan News.Net

Bayer Backs Xarelto Sales Forecast After FDA Panel Votes Against Expanded Use

FRANKFURT German pharmaceutical company Bayer AG Thursday confirmed it sees peak annual sales of its Xarelto drug above EUR2 billion after a U.S. Food and Drug Administration advisory panel voted against expanded use of the blood thinner.The FDA advisers narrowly voted against the use of the anti-clotting pill to treat patients with a heart problem ... (more)

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, e-Spirit, Food and Drug Administration, Microsoft, Startups

Wed May 23, 2012

Reuters

UPDATE 1-US advisers reject new use for J&J/Bayer's Xarelto

U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks and strokes in people with heart problems.

Comment?

Related Topix: Food, J and J Snack Foods, Medicine, Aspirin (generic), Bayer, Alka-Seltzer, Medication, Manufacturing, Biotech, Chemicals, Stroke, Health, Food and Drug Administration, Pain

BioSpace

Bayer HealthCare Pharmaceuticals Submits New Drug Application for...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia /PRNewswire/ -- Bayer HealthCare announced today that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the oral ... (more)

Comment?

Related Topix: Manufacturing, Bayer HealthCare, Chemicals, Healthcare Law, Law, Food and Drug Administration, Oncology, Medicine, Colorectal Health, Colon Cancer, Health, Biotech

Houston Home-Journal

Bayer Submits Regorafenib For EU, US. Marketing Authorization

FRANKFURT German pharmaceutical company Bayer AG's HealthCare unit Wednesday said it applied for marketing authorization in the E.U. and the U.S. for its oral drug Regorafenib, used to threat patients with metastatic colorectal cancer.MAIN FACTS:-Bayer has applied to the European Medicines Agency and the U.S. Food and Drug Administration.-The ... (more)

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, Marketing

Tue May 22, 2012

WNDU-TV South Bend

City opens 1938 Miles Lab time capsule

After more than 70 years hidden in the steps of the old Bayer building, the city of Elkhart opened a Miles Lab time capsule Tuesday night.

Comment?

Related Topix: Manufacturing, Biotech, Medicine, Aspirin (generic), Bayer, Alka-Seltzer, Chemicals, Medication

Fox News

Bayer: Nexavar Lung Cancer Phase III Study Misses Primary Endpoint

German chemical and pharmaceutical group Bayer AG and Onyx Pharmaceuticals, Inc.

Comment?

Related Topix: Health, Lung Cancer, Manufacturing, Biotech, Bayer HealthCare, Chemicals, Startups, Onyx Pharmaceuticals, Oncology, Medicine, Business News

Mon May 21, 2012

Shanghai Daily

Doctor questions new drug's use

A local doctor is questioning whether the German pharmaceutical giant Bayer AG illegally sells and promotes a blood-clotting prevention medicine for a use not approved by China's State Food and Drug Administration.

Comment?

Related Topix: Medicine, Manufacturing, Biotech, Chemicals

Reuters

UPDATE 2-FDA staff sends mixed message on J&J drug Xarelto

U.S. drug reviewers had mixed opinions about whether Johnson & Johnson's blood thinner Xarelto reduced the risk of new heart attacks and strokes in people with heart problems, setting the stage for heated debate by outside experts later this week.

Comment?

Related Topix: Food, J and J Snack Foods, Food and Drug Administration, Stroke, Medicine, Health, Manufacturing, Biotech, Chemicals, Heart Attack

Bloomberg

J&J-Bayer Blood Thinner Xarelto Is Recommended for Expanded Use

Johnson & Johnson and Bayer AG 's blood-thinner Xarelto was recommended for approval to prevent heart attacks by a reviewer for U.S. regulators.

Comment?

Related Topix: Johnson & Johnson, Manufacturing, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Chemicals, Healthcare Industry, Startups, Acclarent, OrthoClinical Diagnostics, Medical Equipment

Reuters

TEXT-Fitch revises Bayer's outlook to positive;afrms at 'A-'

May 21 - Fitch Ratings has revised the Outlook on Germany-based healthcare chemicals group Bayer AG's Long-term Issuer Default Rating to Positive from Stable and affirmed the IDR and senior unsecured ratings at 'A'-. The agency has also affirmed the Short-term IDR at 'F2' and Bayer's EUR1.3bn hybrid bond at 'BBB'. "The Positive Outlook reflects ... (more)

Comment?

Related Topix: Medicine, Aspirin (generic), Bayer, Alka-Seltzer, Medication, Manufacturing, Biotech, Chemicals, Bayer AG, Pharmaceuticals

Fri May 11, 2012

Newkerala.com

AIBA hails patents office's decsion on Nexavar issue

Hyderabad, May 11 : Following the move of German drug maker, Bayer AG, to approach Intellectual Property Appellate Board in the Nexavar battle, the All India Biotech Association - Southern Chapter today appreciated the Indian Patents Office order in favour of Natco Pharma Limited.

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, Bayer HealthCare

Business Journal

OncoMed files for $115 million IPO

The Redwood City-based cancer drug developer, one of the most successful Bay Area biotech companies at raising venture capital over the past five years, said it will use proceeds of the IPO to advance its lead drug -- demcizumab, or OMP-21M18 -- and two other drugs into Phase II clinical trials and for programs with partners GlaxoSmithKline and ... (more)

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, GlaxoSmithKline, e-Spirit, Bayer AG, Pharmaceuticals, Securities and Exchange Commission, Corporate / Securities Law, Law

Thu May 10, 2012

PR-inside.com

Bayer CropScience Honored With "A Better World" Award From Triangle Business Journal

RESEARCH TRIANGLE PARK, NC - Bayer CropScience , one of the world's top innovators in the areas of crop protection, non-agricultural pest control, seeds and traits, received an inaugural "A Better World" award from the Triangle Business Journal for the company's passion and commitment to local nonprofit organizations in the Raleigh area in 2011.

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, Research Triangle Park, NC, Agriculture, Science, Non-Profit

AmericanBankingNews.com

Societe Generale Now Covering Bayer AG

The firm set a "hold" rating on the stock. A number of other analysts have also recently weighed in on BAYRY.

Comment?

Related Topix: e-Spirit, Bayer AG, Manufacturing, Biotech, Pharmaceuticals, Chemicals

Wed May 09, 2012

Milwaukee Journal-Sentinal

InVigorA Canola Supports Communities with More for Everyone Awards

Kids ice-skating in hockey uniforms, working parents needing childcare, teens waiting for the day when they learn agronomy and biology in a greenhouse and many others across North Dakota are joining their canola-growing neighbors in celebrating the benefits of InVigor canola hybrids from Bayer CropScience , as small community groups receive ... (more)

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, Non-Profit, North Dakota State University, Dakota State University, Agriculture, Science

Tue May 08, 2012

Fox News

Bayer Could Get EUR1 Billion With Diabetes Device Unit Sale -Report

Germany's Bayer AG has contacted rivals to sound out their interest in buying its diabetes instrument business, German daily Financial Times Deutschland reported Wednesday, citing sources close to the contacted parties and in the financial sector.

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, Business News

Sun May 06, 2012

India Gazette

Bayer challenges India cancer drug ruling favoring Natco

German pharmaceutical giant Bayer AG has challenged a ground-breaking Indian ruling that allowed a local firm to produce a vastly cheaper copy of its patented drug for kidney and liver cancer.India's patents chief ruled in March the price Bayer charged for the drug, Nexavar, was "exorbitant" and ordered the firm to give a so-called "compulsory ... (more)

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, Bayer AG, Pharmaceuticals

Sat May 05, 2012

Fox News

Bayer Appeals India Patent Office Ruling On Cancer-Drug License

Germany's Bayer AG has appealed against the grant of a compulsory license by India's patent authority to a local generic drug producer for its kidney- and liver-cancer medicine, Nexavar.

Comment?

Related Topix: Manufacturing, Biotech, Chemicals, Business News

Los Angeles Jobs

Also on Topix